Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studies.

Fuente: PubMed

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tang, Wen-Fang, Tsai, Hui-Ping, Chin, Yuan-Fan, Tsai, Shan-Ko, Lin, Cheng-Chin, Ngo, Son Tung, Liang, Po-Huang, Jheng, Jia-Rong, Hsieh, Chung-Fan, Lee, Jin-Ching, Chang, Yu-Hsiu, Chang, Tein-Yao, Lin, Chia-Yi, Lin, Guan-Hua, Cai, Jie-Yun, Chen, Yu-Li, Chen, Yuan-Siao, Liu, Ping-Cheng, Yang, Chuen-Mi, Shadbahr, Tolou, Tang, Jing, Wang, Ling-Yu, Chen, Cheng Cheung, Hsu, Shu-Chen, Lee, Hsin-Yi, Wang, Wen-Chieh, Thai, Quynh Mai, Pham, Minh Quan, Horng, Jim-Tong
Format:	Artículo científico
Langue:	en
Publié:	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025
Sujets:	SARS-CoV-2 Coumarins Antiviral Agents Humans Molecular Docking Simulation Virus Replication COVID-19 Drug Treatment RNA-Dependent RNA Polymerase Chlorocebus aethiops Vero Cells Animals Alanine RNA, Viral Coronavirus RNA-Dependent RNA Polymerase Adenosine Monophosphate COVID-19
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Internet